Last reviewed · How we verify
NCT04664387
Somatic Symptom Disorders in Patients With Myocardial Bridge
trial testing coronary angiography in Myocardial Bridge in 1,357 participants. Completed in 8 May 2020.
8 May 2020
Quick facts
| Lead sponsor | RenJi Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,357 |
| Start date | 30 October 2016 |
| Primary completion | 8 May 2020 |
| Estimated completion | 8 May 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- coronary angiography
Conditions studied
- Myocardial Bridge — all drugs for Myocardial Bridge →
- Somatic Symptom Disorder — all drugs for Somatic Symptom Disorder →
Sponsor
RenJi Hospital
Who can join
18 and older, any sex, with Myocardial Bridge or Somatic Symptom Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was to investigate the prevalence of physical and mental disorder in the population of patients with myocardial bridge and to describe the relationship between clinical features and the occurrence of somatic disorder.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Somatic symptom disorder in patients with myocardial bridge: cross-sectional study in China.
Tao Z, Wu Y, Qiao Y, Wang Z, et al · · 2025 · cited 1× · PMID 40123454 · DOI 10.1192/bjo.2024.851
Verify or expand the search:
- PubMed search for NCT04664387
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of coronary angiography
Trials testing the same drug.
- NCT07293338 — Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy · recruiting
- NCT06949150 — Combined Coronary CT Angiography and CT Perfusion in Coronary Artery Disease (CoroFusion) · recruiting
- NCT04651101 — Vitamin D Deficiency in Coronary Artery Disease · completed
- NCT03194763 — Observational Study for Feasibility and Performance of Sub-millisievert Coronary Computed Tomography Angiography (CCTA) · completed
- NCT03175393 — Relation Between Postprandial Lipogram and Coronary Artery Disease Severity · unknown
Other recruiting trials for Myocardial Bridge
Currently open trials in the same condition.
- NCT06281067 — Reassessment of myocardIAL Bridge TOwards PeRsOnalized Medicine · NA · recruiting
- NCT06857838 — Myocardialbridge Bypass Graft Surgery Efficacy Verification · NA · recruiting
Other RenJi Hospital trials
Trials by the same sponsor.
- NCT07584733 — Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper · Phase 2 · not yet recruiting
- NCT07537725 — EEG-TMS for Postoperative Delirium After Cardiac Surgery · NA · not yet recruiting
- NCT07527936 — A Study of BEN301 Injection in theTreatment of Autoimmune Diseases · EARLY_PHASE1 · not yet recruiting
- NCT07343076 — Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE · NA · not yet recruiting
- NCT07449793 — Biochemical Response and Clinical Outcomes in Patients With PBC · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04664387 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RenJi Hospital
- Last refreshed: 17 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04664387.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing